APA (7th ed.) Citation

Zarogoulidis, P., Hofenforst-Schwidt, W., Huang, H., Tryfon, S., Zhang, Y., Ma, G., . . . Baka, S. (2026). CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons. Journal of Cancer, 17(6), 1187. https://doi.org/10.7150/jca.136122

Chicago Style (17th ed.) Citation

Zarogoulidis, Paul, et al. "CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G Needle: Pros and Cons." Journal of Cancer 17, no. 6 (2026): 1187. https://doi.org/10.7150/jca.136122.

MLA (9th ed.) Citation

Zarogoulidis, Paul, et al. "CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G Needle: Pros and Cons." Journal of Cancer, vol. 17, no. 6, 2026, p. 1187, https://doi.org/10.7150/jca.136122.